InsidersTradesSigma
리가켐바이오: directors' dealings · South Korea · DART (FSS)
DART:company-43852dKR·DART (FSS)Mcap 6323.6Bn€
Explore the full directors' dealings record of 리가켐바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €6,323.6bn. The latest transaction was disclosed on 1 April 2026 (Sale). Among the most active insiders: 김형석. All data is accessible without an account.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
162000.00 €
Income statement
Revenue141.55 Bn€
Gross profit126.00 Bn€89% margin
Net income−74.28 Bn€-52.5% margin
Balance sheet & cash
Market cap6323.57 Bn€
Total debt2.75 Bn€
Free Cash Flow−130.57 Bn€
Last declaration on 1 April 2026